Characteristics of O157:H7-specific infection bacteriophages (O157 coliphages) and broad-host-range bacteriophages for other serotypes (broad-host coliphages) were compared. The burst sizes of the two groups ranged from 40 to 176 PFU/infected cell. Distributions of the virulence factors ,, , and between the two groups were not differentiated. Broad-host-range coliphages showed lower stability at 70°C, in relation to O157 coliphages. However, O157 coliphages showed high acid and ethanol tolerance by reduction of only 22% and 11% phages, respectively, under pH 3 and 70% ethanol for 1 h exposure. Therefore, these results revealed that the O157 coliphages might be more stable under harsh environments, which might explain their effective infection of the acid-tolerant O157:H7.
We
report herein a Lewis pair-catalyzed process for the regio-
and stereoselective addition of secondary phosphine oxides (SPOs)
to allenoates. A Lewis pair composed of B(C6F5)3 and P(4-OMeC6H4)3 dissociates
into a free acid and base under reaction conditions, thereby creating
key reaction intermediates that enable the atom-economical generation
of an array of alkenylphosphorus building blocks. Mechanistic studies
indicate that this process proceeds through a catalytic cycle wherein
the deprotonation of a P–H bond of a SPO (coordinated to a
boron catalyst) by the phosphonium zwitterion (resulting from the
nucleophilic addition of a phosphine catalyst to allenoates) is the
rate-determining step. Subsequent addition of the phosphinite anion
to allenoate substrates furnishes β-addition products, while
the reaction between the pair of the phosphinite anion and alkenylphosphonium
cation affords γ-addition products.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.